FGF19 and obesity disorder: Post hoc analysis with Bonferroni correction further demonstrated significantly lower FGF-19 concentrations in diabetic patients with overweight (p < 0.01) and obesity (p < 0.001) compared to those with a normal BMI (see Figure 3).